Get the Stockscreener App
1.53
1.29%
-0.02
Equillium Inc stock is traded at $1.53, with a volume of 387.48K.
It is down -1.29% in the last 24 hours and up +15.04% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$1.55
Open:
$1.51
24h Volume:
387.48K
Relative Volume:
0.07
Market Cap:
$91.04M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-10.91
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
+13.33%
1M Performance:
+15.04%
6M Performance:
+264.29%
1Y Performance:
+103.97%
1-Day Range:
$1.44
$1.56
1-Week Range:
$1.3164
$1.58
52-Week Range:
$0.27
$2.35
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.53 | 92.23M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.56 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.13 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.17 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.47 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.40 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
Equillium to Participate in Upcoming Investor Conferences - The Manila Times
Equillium (NASDAQ: EQ) sets Stifel presentation Nov. 12; 90-day replay available - Stock Titan
Tick level data insight on Equillium Inc. volatility2025 Pullback Review & Low Risk Growth Stock Ideas - newser.com
Volatility clustering patterns for Equillium Inc.July 2025 Setups & AI Enhanced Trading Signals - newser.com
Applying chart zones and confluence areas to Equillium Inc.Trade Volume Summary & Growth Focused Investment Plans - newser.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Equillium (NASDAQ: EQ) grants inducement options for 7,200 shares with four-year vesting - Stock Titan
Can Equillium Inc. stock rebound after recent weaknessQuarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
Using Ichimoku Cloud for Equillium Inc. technicalsMarket Risk Analysis & Low Risk High Reward Trade Ideas - newser.com
Full technical analysis of Equillium Inc. stock2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
Is Equillium Inc. (0FY) stock at risk of policy regulationJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Will Equillium Inc. stock sustain high P E ratiosMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Real time breakdown of Equillium Inc. stock performanceTrade Risk Summary & Technical Pattern Based Signals - newser.com
Institutional scanner results for Equillium Inc.2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com
Intraday pattern recognizer results for Equillium Inc.2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Why Equillium Inc. (0FY) stock stays undervaluedWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
How Equillium Inc. stock performs during Fed tightening cycles2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Is Equillium Inc. stock poised for growthTrade Analysis Report & Daily Growth Stock Investment Tips - newser.com
Equillium (NASDAQ:EQ) Trading Up 3.6%What's Next? - MarketBeat
Why Equillium Inc. (0FY) stock is upgraded to buyMarket Risk Analysis & Growth Focused Stock Reports - newser.com
How to monitor Equillium Inc. with trend dashboardsPortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Equillium, Inc. (EQ) Analyst insights, Price targets and Recommendations - Yahoo! Finance Singapore
How Equillium Inc. stock performs after earningsJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Can a trend reversal in Equillium Inc. lead to recoveryJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
Is it too late to sell Equillium Inc.2025 Biggest Moves & Fast Moving Market Watchlists - newser.com
Short Interest in Equillium, Inc. (NASDAQ:EQ) Drops By 64.2% - MarketBeat
What to expect from Equillium Inc. in the next 30 days2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Why Equillium Inc. stock remains a top recommendationJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - fcp.pa.gov.br
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):